Miriam Staunton shared her journey with melanoma, emphasizing that despite having no skin lesions and it being stage three, she was misdiagnosed initially.
Staunton highlights the importance of new treatments through early-phase trials: 'They offer an opportunity for patients who have been failed by existing available treatments.'
Reflecting on her experience, Staunton stated, 'Those of us who are the beneficiaries of the recent huge strides in cancer treatments know how important it is to support ongoing research and development.'
Miriam Staunton, now a patient advocate, emphasizes the need for access to innovative cancer trials for better treatment options and future patient care.
Collection
[
|
...
]